title: Network meta-analyses should be the highest level of evidence in treatment guidelines.
authors.affiliation: Department of Psychiatry and Psychotherapy, Technische Universität München Klinikum rechts der Isar, Ismaningerstr. 22, 81675, Munich, Germany. Stefan.Leucht@tum.de.
authors.forename: Stefan
authors.initials: S
authors.lastname: Leucht
authors.affiliation: Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, University Campus Ioannina, 45110, Ioannina, Greece.
authors.forename: Anna
authors.initials: A
authors.lastname: Chaimani
authors.affiliation: Department of Psychiatry, Warneford Hospital, University of Oxford, Oxford, OX3 7JX, UK.
authors.forename: Andrea S
authors.initials: AS
authors.lastname: Cipriani
authors.affiliation: Psychiatric Institute, University of Illinois at Chicago, 1601 W. Taylor St., Chicago, IL, 60612, USA.|Maryland Psychiatric Research Center, Baltimore, MD, USA.
authors.forename: John M
authors.initials: JM
authors.lastname: Davis
authors.affiliation: Departments of Health Promotion and Human Behavior and of Clinical Epidemiology, Kyoto University Graduate School of Medicine/School of Public Health, Kyoto, Japan.
authors.forename: Toshi A
authors.initials: TA
authors.lastname: Furukawa
authors.affiliation: Institute of Social and Preventive Medicine (ISPM) and Berner Institut für Hausarztmedizin (BIHAM), University of Bern, Finkenhubelweg 11, 3012, Bern, Switzerland.
authors.forename: Georgia
authors.initials: G
authors.lastname: Salanti
mesh_terms: D014150:Antipsychotic Agents / Q000592:standards / Q000627:therapeutic use; D019317:Evidence-Based Medicine; D017408:Guidelines as Topic; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy; D000071076:Network Meta-Analysis as Topic
chemical_list: D014150:Antipsychotic Agents